AGP Executive Report
Last update: 2 hours agoHungary biotech: Gedeon Richter and Hetero Labs signed a global collaboration to jointly develop, register and commercialize semaglutide generics, with EU and US submissions planned for 2027. Cancer diagnostics: Urteste enrolled the first patient in its Panuri urine-based pancreatic cancer study, aiming for interim results in Q4 2026. EV industry in Hungary: BYD says it will prioritize Hungary after pausing a planned Turkey plant, while also pushing its ambition to become the world’s biggest automaker within five years. Energy tech: Rondo Energy’s modular thermal storage “heat battery” targets industrial heat and steam use by charging with renewable power and storing heat for days. EU policy & security mood: A new ECFR survey finds only 11% of Europeans see the US as an ally, boosting support for stronger European defense spending. Local business pressure: Coface reports late payments are widespread among Hungarian SMEs, raising insolvency risks. Media freedom: An EFJ workshop in Brussels focused on how EU rules like the Media Freedom Act and AI Act should work in practice for journalists. Industry ties: Bahrain–Hungary’s industrial partnership forum highlighted engineering, AI, renewables and logistics cooperation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
